NASDAQ:IRTC iRhythm Technologies (IRTC) Stock Price, News & Analysis $104.78 +2.14 (+2.08%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$104.21 -0.57 (-0.54%) As of 08:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About iRhythm Technologies Stock (NASDAQ:IRTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get iRhythm Technologies alerts:Sign Up Key Stats Today's Range$103.34▼$106.0250-Day Range$96.84▼$119.5852-Week Range$55.92▼$128.52Volume236,053 shsAverage Volume457,782 shsMarket Capitalization$3.34 billionP/E RatioN/ADividend YieldN/APrice Target$119.73Consensus RatingModerate Buy Company OverviewiRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.Read More… iRhythm Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScoreIRTC MarketRank™: iRhythm Technologies scored higher than 21% of companies evaluated by MarketBeat, and ranked 828th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.4 / 5Analyst RatingModerate Buy Consensus RatingiRhythm Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageiRhythm Technologies has only been the subject of 4 research reports in the past 90 days.Read more about iRhythm Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for iRhythm Technologies are expected to grow in the coming year, from ($1.98) to ($1.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of iRhythm Technologies is -28.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of iRhythm Technologies is -28.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioiRhythm Technologies has a P/B Ratio of 15.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about iRhythm Technologies' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.43% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 0.34%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiRhythm Technologies does not currently pay a dividend.Dividend GrowthiRhythm Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.43% of the float of iRhythm Technologies has been sold short.Short Interest Ratio / Days to CoveriRhythm Technologies has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in iRhythm Technologies has recently increased by 0.34%, indicating that investor sentiment is decreasing. News and Social Media3.6 / 5News Sentiment1.41 News SentimentiRhythm Technologies has a news sentiment score of 1.41. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for iRhythm Technologies this week, compared to 5 articles on an average week.MarketBeat Follows2 people have added iRhythm Technologies to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iRhythm Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.68% of the stock of iRhythm Technologies is held by insiders.Read more about iRhythm Technologies' insider trading history. Receive IRTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address IRTC Stock News HeadlinesiRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025April 17, 2025 | globenewswire.comiRhythm Technologies Releases 2024 Corporate Sustainability Report That Demonstrates Ongoing Commitment to Culture of Quality and SustainabilityApril 16, 2025 | globenewswire.comElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.April 25, 2025 | Brownstone Research (Ad)iRhythm price target lowered to $120 from $145 at TruistApril 12, 2025 | markets.businessinsider.com3 Reasons IRTC is Risky and 1 Stock to Buy InsteadApril 10, 2025 | msn.comiRhythm announces results from two studies presented at ACC on LTCM ECG devicesMarch 31, 2025 | markets.businessinsider.comiRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia DetectionMarch 31, 2025 | globenewswire.com3 Healthcare Stocks in the DoghouseMarch 26, 2025 | theglobeandmail.comSee More Headlines IRTC Stock Analysis - Frequently Asked Questions How have IRTC shares performed this year? iRhythm Technologies' stock was trading at $90.17 on January 1st, 2025. Since then, IRTC stock has increased by 16.2% and is now trading at $104.78. View the best growth stocks for 2025 here. How were iRhythm Technologies' earnings last quarter? iRhythm Technologies, Inc. (NASDAQ:IRTC) announced its earnings results on Thursday, February, 20th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.29) by $0.30. The firm earned $164.33 million during the quarter, compared to analysts' expectations of $158.30 million. iRhythm Technologies had a negative net margin of 19.14% and a negative trailing twelve-month return on equity of 118.83%. Read the conference call transcript. When did iRhythm Technologies IPO? iRhythm Technologies (IRTC) raised $76 million in an initial public offering (IPO) on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers. Who are iRhythm Technologies' major shareholders? iRhythm Technologies' top institutional investors include Bessemer Group Inc. (1.83%), Allspring Global Investments Holdings LLC (1.62%), Harbor Capital Advisors Inc. (0.17%) and Rhumbline Advisers (0.15%). Insiders that own company stock include Quentin S Blackford, Mark J Day, Chad Patterson, Patrick Michael Murphy, Daniel G Wilson, Douglas Devine, Minang Turakhia, Brice Bobzien, Sumi Shrishrimal, Abhijit Y Talwalkar, Mervin Smith, Marc W Rosenbaum and Merz Cathleen Noel Bairey. View institutional ownership trends. How do I buy shares of iRhythm Technologies? Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of iRhythm Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that iRhythm Technologies investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Advanced Micro Devices (AMD), Arista Networks (ANET) and ServiceNow (NOW). Company Calendar Last Earnings2/20/2025Today4/25/2025Next Earnings (Estimated)5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRTC CIK1388658 Webwww.irhythmtech.com Phone(415) 632-5700FaxN/AEmployees1,790Year FoundedN/APrice Target and Rating Average Stock Price Target$119.73 High Stock Price Target$152.00 Low Stock Price Target$79.00 Potential Upside/Downside+14.3%Consensus RatingModerate Buy Rating Score (0-4)2.82 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($3.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-123,410,000.00 Net Margins-19.14% Pretax Margin-26.78% Return on Equity-118.83% Return on Assets-11.34% Debt Debt-to-Equity Ratio9.00 Current Ratio6.27 Quick Ratio6.12 Sales & Book Value Annual Sales$591.84 million Price / Sales5.65 Cash FlowN/A Price / Cash FlowN/A Book Value$6.85 per share Price / Book15.30Miscellaneous Outstanding Shares31,920,000Free Float31,085,000Market Cap$3.34 billion OptionableOptionable Beta1.45 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:IRTC) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.